Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets

Pfizer

Status: Completed

Conditions: Smoking Cessation

Treatments: Drug: varenicline

Study type: Observational

Funder types: Industry

Identifiers

NCT00483002

A3051083

Details and patient eligibility

About

To monitor use in real practice including safety and efficacy of Champix tablets 0.5mg, 1mg medication for 12 weeks in smokers

Full description

No sampling method will be applied to this study.

Enrollment: 3,719 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects selected for this study are those who would have been prescribed Champix tablets by the physician according to the subject's condition in usual clinical practice.

Exclusion criteria

• None

Trial design

3,719 participants in 1 patient group

Healthy smokers

Treatment:

Drug: varenicline